tiprankstipranks
Singular Genomics Systems (OMIC)
NASDAQ:OMIC
US Market
Holding OMIC?
Track your performance easily

Singular Genomics Systems (OMIC) Stock Forecast & Price Target

81 Followers
See the Price Targets and Ratings of:

OMIC Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Singular
Genomics Systems
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OMIC Stock 12 Month Forecast

There Are No Analyst Ratings for OMIC In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

OMIC Financial Forecast

OMIC Earnings Forecast

Next quarter’s earnings estimate for OMIC is -$8.10 with a range of -$8.10 to -$8.10. The previous quarter’s EPS was -$6.72. OMIC beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.95% of the time in the same period. In the last calendar year OMIC has Underperformed its overall industry.
Next quarter’s earnings estimate for OMIC is -$8.10 with a range of -$8.10 to -$8.10. The previous quarter’s EPS was -$6.72. OMIC beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.95% of the time in the same period. In the last calendar year OMIC has Underperformed its overall industry.

OMIC Sales Forecast

Next quarter’s sales forecast for OMIC is $1.77M with a range of $1.77M to $1.77M. The previous quarter’s sales results were $406.00K. OMIC beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.79% of the time in the same period. In the last calendar year OMIC has Outperformed its overall industry.
Next quarter’s sales forecast for OMIC is $1.77M with a range of $1.77M to $1.77M. The previous quarter’s sales results were $406.00K. OMIC beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.79% of the time in the same period. In the last calendar year OMIC has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
$22.5$6.5
Hold
-70.02%
Downside
Reiterated
07/08/24
Singular Genomics (OMIC) PT Lowered to $6.50 at Goldman SachsGoldman Sachs analyst Matthew Sykes lowered the price target on Singular Genomics (NASDAQ: OMIC) to $6.50 (from $22.50) while maintaining a Neutral rating.
UBS
$12$15
Hold
-30.81%
Downside
Reiterated
03/20/24
Singular Genomics (OMIC) PT Raised to $0.50 at UBSUBS analyst John Sourbeer raised the price target on Singular Genomics (NASDAQ: OMIC) to $0.50 (from $0.40) while maintaining a Neutral rating.

OMIC Analyst Recommendation Trends

Rating
Mar 24
May 24
Jul 24
Aug 24
Sep 24
Strong Buy
0
0
0
0
0
Buy
2
2
2
2
1
Hold
3
3
3
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
5
4
3
In the current month, OMIC has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. OMIC average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

OMIC Stock Forecast FAQ

What is OMIC’s average 12-month price target, according to analysts?
Currently, no data Available
What is OMIC’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for OMIC, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is OMIC a Buy, Sell or Hold?
      Currently, no data Available
      What is Singular Genomics Systems’s price target?
      Currently, no data Available
      What do analysts say about Singular Genomics Systems?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of OMIC?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis